Brief: China Medical System Announces Equity Transfer & Capital Increase Agreements
May 17 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* GROUP, VIA A UNIT, ENTERED EQUITY TRANSFER & CAPITAL
INCREASE
AGREEMENTS WITH SHANGHAI A&S SCIENCE TECHNOLOGY DEVELOPMENT CO
* POST TRANSACTION, GROUP WILL HOLD ABOUT 64.81% STAKE OF
SHANGHAI
CARNATION MEDICAL TECHNOLOGY CO
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0517/2021051701054.pdf
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says